BSE - Delayed Quote
INR
Eris Lifesciences Limited (ERIS.BO)
1,163.25
+3.65
(+0.31%)
At close: 3:28:32 PM GMT+5:30
Loading chart for ERIS.BO
- Previous Close
1,159.60 - Open
1,160.00 - Bid 1,160.00 x --
- Ask 1,164.10 x --
- Day's Range
1,154.05 - 1,187.40 - 52 Week Range
1,069.00 - 1,737.00 - Volume
3,128 - Avg. Volume
29,866 - Market Cap (intraday)
161.388B - Beta (5Y Monthly) -0.05
- PE Ratio (TTM)
22.62 - EPS (TTM)
51.42 - Earnings Date (est.) --
- Forward Dividend & Yield 14.42 (1.24%)
- Ex-Dividend Date May 29, 2026
- 1y Target Est
1,514.40
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
ERIS.BO
22.23%
S&P BSE SENSEX (^BSESN)
11.18%
1-Year Return
ERIS.BO
26.40%
S&P BSE SENSEX (^BSESN)
9.82%
3-Year Return
ERIS.BO
35.87%
S&P BSE SENSEX (^BSESN)
18.12%
5-Year Return
ERIS.BO
47.93%
S&P BSE SENSEX (^BSESN)
26.09%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
21.37%
-
Return on Assets (ttm)
7.42%
-
Return on Equity (ttm)
18.79%
-
Revenue (ttm)
33.12B
-
Net Income Avi to Common (ttm)
7.08B
-
Diluted EPS (ttm)
51.42
Balance Sheet and Cash Flow
-
Total Cash (mrq)
2.54B
-
Total Debt/Equity (mrq)
58.66%
-
Levered Free Cash Flow (ttm)
415.54M
